Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
ANI Pharmaceuticals (ANIP) Ownership - Who Owns ANI Pharmaceuticals?
255 Followers
ANI Pharmaceuticals (ANIP) Ownership Overview
41.36% Insiders
15.91% Mutual Funds
19.39% Other Institutional Investors
23.34% Public Companies and
Individual Investors
The ownership structure of ANI Pharmaceuticals (ANIP) stock is a mix of institutional, retail and individual investors. Approximately 35.30% of the company’s stock is owned by Institutional Investors, 41.36% is owned by Insiders and 23.34% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 11, 2024 | Stephen P. Carey Svp & Cfo | Sold | $791687 |
| Mar 08, 2024 | Nikhil Lalwani President & Ceo,director | Sold | $4129541 |
| Mar 07, 2024 | James Marken Svp Ops & Prod Dev | Sold | $1751001 |
| Mar 06, 2024 | Christopher Mutz Head Of Rare Disease | Sold | $330000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $281048 | |
| Dec 31, 2023 | Bought | $349973 | |
| Dec 31, 2023 | Bought | $443987 | |
| Dec 31, 2023 | Bought | $511092 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,819,259 | Insider | 8.67% | 118,906,768 | |
| 1,799,700 | Institution | 8.58% | 117,628,392 | |
| 964,832 | Institution | 4.60% | 63,061,420 | |
| 741,778 | Institution | 3.54% | 48,482,610 | |
| 370,585 | Institution | 1.77% | 24,221,436 | |
| 349,934 | Insider | 1.67% | 22,871,686 | |
| 308,967 | Institution | 1.47% | 20,194,103 | |
| 289,003 | Insider | 1.38% | 18,889,236 | |
| 255,521 | Institution | 1.22% | 16,700,853 | |
| 193,870 | Institution | 0.92% | 12,671,343 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 741,778 | Institution | 3.54% | 48,482,610 | |
| 370,585 | Institution | 1.77% | 24,221,436 | |
| 193,870 | Institution | 0.92% | 12,671,343 | |
| 158,235 | Institution | 0.75% | 10,342,240 | |
| 156,300 | Institution | 0.74% | 10,215,768 | |
| 154,665 | Institution | 0.74% | 10,108,904 | |
| 146,890 | Institution | 0.70% | 9,600,730 | |
| 117,779 | Institution | 0.56% | 7,698,035 | |
| 103,131 | Institution | 0.49% | 6,740,642 | |
| 102,545 | Institution | 0.49% | 6,702,341 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,012,017 | Institution | 4.82% | 66,934,804 | |
| 507,773 | Institution | 2.42% | 35,102,347 | |
| 348,723 | Institution | 1.66% | 23,064,539 | |
| 235,218 | Institution | 1.12% | 16,260,620 | |
| 168,177 | Institution | 0.80% | 10,923,096 | |
| 147,050 | Institution | 0.70% | 9,725,887 | |
| 134,175 | Institution | 0.64% | 8,779,070 | |
| 96,150 | Institution | 0.46% | 6,359,361 | |
| 84,475 | Institution | 0.40% | 5,543,250 | |
| 71,190 | Institution | 0.34% | 4,708,507 |
FAQ
Who Owns ANI Pharmaceuticals Inc (ANIP)?
According to the latest TipRanks data, approximately 19.39% of the company's stock is held by institutional investors, 41.36% is held by insiders, and 23.34% is held by retail investors.
What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.39% of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors.
What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.34% of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors.
Who owns the most shares of ANI Pharmaceuticals Inc (ANIP)?
Meridian Venture Partners Lp owns the most shares of ANI Pharmaceuticals Inc (ANIP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.